Our year 2016/17
Watch this video to find out about just a few of our top moments of 2016/17.
Thanks to you we're beating cancer
Your support helps us to fund life-saving research into the causes, prevention and treatment of cancer. Without you, none of this would be possible – thank you.
Our Annual Review 2016/17 is packed with highlights of our work across the UK and the inspiring stories of people who have benefited from it. Read on to discover some of the ways your support is making a difference.
Highlights from our Annual Review 2016/17
Opening the Francis Crick Institute
Officially opened in November 2016, the Francis Crick Institute (the Crick) is the size of 17.5 football fields. Inside, scientists and medical professionals from different disciplines are collaborating to transform the way we do research. Alongside partners, we co-funded the building of the Crick to house groundbreaking research into cancer and other diseases.
Cutting obesity down to size
After smoking, obesity is the second biggest single preventable cause of cancer. We're tackling obesity from all angles: raising awareness, campaigning for the Government to take action and carrying out research into how obesity causes cancer. Kath Bebbington was diagnosed with womb cancer in 2014. She now helps us to promote healthier lifestyles.
Funding research into early diagnosis
Detecting and diagnosing cancer early can help more people get effective treatment and reduce unnecessary anxiety. That's why we're funding the CanTest Collaborative, revolutionary reserach looking at how GPs could use more tests to help them rule out cancer or speed up a diagnosis. Our researchers Dr Fiona Walter and Professor Willie Hamilton are leading the project.
Tackling hard-to-treat cancers
Some types of cancer are hard to treat - like brain tumours, and lung, pancreatic and oesophageal cancers. Accelerating progress against these hard-to-treat cancers is a priority for Cancer Research UK. Peter Breaden took part in ESPAC-4, a Cancer Research UK-funded clinical trial that has led to a call for a new standard treatment for people with pancreatic cancer who have had surgery.
Bringing better drugs to patients
We currently support around 220 clinical trials across the UK. Dr Udai Banerji is a Cancer Research UK clinican scientist at The Institute of Cancer Research, London. He works in the early stages of drug development, where new drugs are given to patients for the first time to see how they work in the body.